The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3417294
WO Application Number:
US2017017804
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17753704.0
WO Publication Number:
WO2017142871
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Sweden (SE)
Publications:
Dates
Filing date:
14/02/2017
Grant date:
01/12/2021
EP Publication Date:
26/12/2018
WO Publication Date:
24/08/2017
Claims Translations Received Date:
Claims Translation B1 Received Date:
16/02/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
01/12/2021
EP B1 Publication Date:
01/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
13/02/2037
Lapsed By Expiration Date:
Patent Validated Date:
02/03/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
16/05/2022
Name:
The United States of America, as Represented By the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer
6701 Rocklegde Drive
Suite 700, MSC 7788, 20892, Bethesda, MD, United States of America (US)
From:
01/12/2021
Name:
Astrazeneca AB
Address:
151 85 Södertälje, Sweden (SE)
Historical Applicant/holder
From:
01/12/2021
To:
16/05/2022
Name:
The United States of America, as Represented By the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard
Suite 325 MSC 7660, Bethesda, MD 20892-7660, United States of America (US)